Paragraf to Study New POC Test to Guide Antibiotic Selection NanoDx Prepares for Point-of-Care Commercialization Sherlock Biosciences Adds to Infectious Disease Dx Toolkit ![]() Recent Developments - Importance and How to Use This Section Molecular Dx - Infectious Disease Recent Developments Point of Care - Why Centralization is Losing Steam Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance.Īging Population a Boon for All Diagnostics Players are reporting double-digit growth. Point of Care testing is proving itself in the market. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care.Īre targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Point of Care testing move into the Physician's Office or even the Home? Infectious disease Dx is changing and will change more in the future. The report forecasts the market size out for five years. It could possibly displace most frontline test protocols AND save money at the same time. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. Learn about this market including the issues and outlooks. ![]() ![]() With Executive Guides and Customization 2023 - 2027 " report has been added to 's offering. By Application, Technology, Place, Product and by Country. Dublin, (GLOBE NEWSWIRE) - The "Molecular Diagnostics at the Point of Care.
0 Comments
Leave a Reply. |